Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden-Reference-Cited by-同舟云学术

Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden

Published:2020-03-03 Issue:2 Volume:54 Page:115-121
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Aly Markus¹²³,Leval Amy¹⁴,Schain Frida⁴⁵⁶,Liwing Johan⁴⁶,Lawson Joe⁷,Vágó Emese⁸,Nordström Tobias¹⁹^ORCID,Andersson Therese M.-L.¹,Sjöland Erik⁷,Wang Chen¹,Eloranta Sandra¹⁰,Akre Olof²¹¹^ORCID

Affiliation:

1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;

2. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;

3. Department of Urology, Karolinska Institutet, Stockholm, Sweden;

4. Janssen Global Services, Stockholm, Sweden;

5. Schain Research AB, Stockholm, Sweden;

6. Department of Medicine, Karolinska Institutet, Stockholm, Sweden;

7. Department of Oncology, Janssen Research and Development, Raritan, NJ, USA;

8. Janssen Cilag Kft, Budapest, Hungary;

9. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden;

10. Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden;

11. Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2020.1739139

Reference23 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Systems Pathology Approach for the Prediction of Prostate Cancer Progression After Radical Prostatectomy

3. Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer

4. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

5. Abiraterone and Increased Survival in Metastatic Prostate Cancer

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study;Pathology;2024-02

2. Molecular imaging of PARP in cancer: state-of-the-art;Expert Review of Molecular Diagnostics;2023-11-27

3. Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry;European Journal of Nuclear Medicine and Molecular Imaging;2023-10-27

4. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer;JAMA Network Open;2023-10-11

5. Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression;Scientific Reports;2023-09-15